KIMBERLY RUSZCZYK: Open Payments
NPI 1508419409 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 37 payments from 9 companies in 2025. Trend: 2023 $732 · 2024 $595 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 24 | $223 |
| Abbott Laboratories | 1 | $138 |
| Collegium Pharmaceutical, Inc. | 6 | $90 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: General - Pain Management, PROCLAIM, XTAMPZA, JOURNAVX, TONMYA, QULIPTA, ZEPBOUND, RELISTOR.
Industry payments across NY — which companies pay providers there.
